Caris Diagnostics company information, Employees & Contact Information

Caris Life Sciences to Report Third Quarter 2025 Financial Results on November 5, 2025 Sahm

Caris Life Sciences (NASDAQ: CAI) sets Nov 5 webcast at 3:30 p.m. CT for quarterly results Stock Titan

Caris Life Sciences Reports Second Quarter 2025 Financial Results PR Newswire

The Role of IHC Expanding the List of Potential Targets – Caris Life Sciences Oncodaily

Caris Life Sciences: CAI IPO, Health Care - Offers an AI-powered molecular diagnostics platform focused on oncology. renaissancecapital.com

CAI Stock Price and Chart — NASDAQ:CAI TradingView

AI TechBio Pioneer Caris Life Sciences Sets Q2 Earnings Call: Key Details for Precision Medicine Investors Stock Titan

Caris Life Sciences Receives FDA Approval for MI Cancer Seek™ as a Companion Diagnostic (CDx) Test PR Newswire

Dr. Milan Radovich, Ph.D., Joins Caris Life Sciences as Chief Precision Medicine Officer PR Newswire

Caris Life Sciences Appoints Eric Matthews as Chief Business Officer, Biopharma Business Development PR Newswire

Caris Life Sciences Collaborates with Meaningful Insights Biotech Analytics (MiBA) to Advance Oncology Education and Quality of Care PR Newswire

Caris Life Sciences and Moderna Announce Multi-Year Strategic Partnership to Advance mRNA-Based Oncology Therapeutics PR Newswire

Caris Life Sciences Accelerates Growth Through Development of Pioneering State-of-the-Art Corporate Park PR Newswire

Caris Life Sciences Announces New Study Demonstrating the Power and Clinical Utility of its Caris Assure® Blood-Based Assay for Multi-Cancer Early Detection, Minimal Residual Disease and Therapy Selection PR Newswire

Caris Life Sciences and COTA, Inc. Announce Collaboration to Expand Collective Multi-Modal Data Offering PR Newswire

Caris Life Sciences Raises $168 Million in Private Capital from Leading Investors to Continue Platform Expansion PR Newswire

Caris Life Sciences Announces a Strategic Collaboration with Ontada® to Advance Oncology Research and the Adoption of Precision Medicine PR Newswire

Caris Life Sciences and ConcertAI Expand Partnership to Create First-in-Class, Prospectively Matched Clinico-Genomic Research Platform PR Newswire

Caris Life Sciences and Ono Pharmaceutical Announce Strategic Collaboration Leveraging Caris' Novel, Blood-Based cNAS Molecular Profiling Assay Across Several Ono Clinical Studies PR Newswire

Caris Life Sciences Appoints Dr. James Hamrick as Chairman of the Caris Precision Oncology Alliance PR Newswire

Caris Life Sciences Raises $310 Million in Growth Capital from a Broad Syndicate of Leading Investors PR Newswire

Caris Life Sciences Announces Appointment of Dave Fredrickson to Board of Directors PR Newswire

Caris Life Sciences Publishes Landmark Study Demonstrating the Superiority of Caris Assure™ PR Newswire

Caris Life Sciences Raises $830 Million in Growth Equity Capital to Continue to Expand its Precision Medicine Platform PR Newswire

Caris Life Sciences Showcases Data Demonstrating the Clinical Value of Clonal Hematopoiesis Identification and Subtraction in Liquid Biopsy to Improve the Accuracy of Treatment Recommendations PR Newswire

Caris Life Sciences Announces Appointment of Dr. Jeffrey Vacirca to Board of Directors PR Newswire

Caris Life Sciences Announces Partnership with Merck KGaA, Darmstadt, Germany to Discover Novel Cancer Targets and Accelerate First-In-Class Antibody Drug Conjugate Development PR Newswire

Caris Life Sciences and ESSA Pharma Announce Liquid Biopsy Profiling Collaboration PR Newswire

Caris Life Sciences and Flatiron Health Partner to Create Transformational Real-World Data Offering PR Newswire

Caris Life Sciences Raises $400 Million in Senior Secured Debt PR Newswire

Caris Life Sciences Acquires Pharmatech PR Newswire

Caris Life Sciences Announces Appointment of Russ Denton as General Counsel PR Newswire

Caris Life Sciences and Ambry Genetics Partner to Advance Cancer Care PR Newswire

Caris Life Sciences and Xencor Expand Target Discovery Collaboration for Novel XmAb® Antibody Drug Candidates PR Newswire

Dr. George W. Sledge, Jr. Joins Caris Life Sciences as Chief Medical Officer PR Newswire

Caris Life Sciences Announces Appointment of Mike Weinstein, Medical Technology Executive and Wall Street Veteran, as Chief Financial Officer PR Newswire

Rutgers Cancer Institute of New Jersey Joins Caris Life Sciences' Precision Oncology Alliance PR Newswire

Caris Life Sciences and Xencor Enter Target Discovery Collaboration and License Agreement for Novel XmAb® Bispecific Antibodies PR Newswire

Pramana and Caris Life Sciences Collaborate to Digitize 1.5 Million Pathology Slides Annually Business Wire

Joseph J. Frendo Joins Caris Life Sciences as Chief Operations Officer PR Newswire

Central Jersey Daily Rundown, Friday, May 29 Central New Jersey News